Skip to content

Clinical trials

Observational Carcinoma, Transitional Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Observational Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20193
20201
20211
20223
20234
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting4
Completed2
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital6
AnchorDx Medical Co., Ltd.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Creative Biosciences (Guangzhou) Co., Ltd.1
Henan Provincial People's Hospital1
Peking University First Hospital1
Ruijin Hospital1
Sichuan Provincial People's Hospital1
The First Affiliated Hospital of Xinxiang Medical College1
Tianjin Medical University Second Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell18
Urinary Bladder Neoplasms8
Disease4
Hematuria3
Ureteral Neoplasms3
Neoplasms2
Recurrence2
Chromosome Aberrations1
Cystitis1
Disease Progression1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.